Sylph Pharmaceutical Private Limited
About Sylph Pharmaceutical Private Limited
Data last updated:
Sylph Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC143646.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nagarjuna Reddy Devireddy and Devi S L V K Lankalapalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.13 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 0.9%) and EBITDA of ₹4.71 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sylph Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No 44 Sy No 166, Sri Sai Nagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sylph Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sylph Pharmaceutical Private Limited, buy the company report.
Financials of Sylph Pharmaceutical Private Limited
FY 2025 filings availableSylph Pharmaceutical Private Limited reported revenue of ₹1.13 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 59%. EBITDA rose 213% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sylph Pharmaceutical Private Limited, buy the company report.
Board of directors of Sylph Pharmaceutical Private Limited
Sylph Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagarjuna Reddy Devireddy Also directs: My3 Pharma Private Limited | Director | 08 Sep 2020 | 6 Years 1 Months | Current |
| Devi S L V K Lankalapalli | Director | 08 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Sylph Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biospan Contamination Control Solutions Private Limited | ₹1.13 Cr (FY 2025) | -15.0% | Surat, Gujarat, India | |||
| Moovalley Agro Products Private Limited | ₹1.13 Cr (FY 2023) | Mumbai, Maharashtra, India | ||||
| Medicrux Healthcare Private Limited | ₹1.13 Cr (FY 2025) | 42.0% | Khopoli, Maharashtra, India | |||
| Air Digilife Private Limited | ₹1.13 Cr (FY 2025) | Mumbai, Maharashtra, India | ||||
| Visamonk Private Limited | ₹1.13 Cr (FY 2025) | -4.0% | Noida, Uttar Pradesh, India | |||
| Sylph Pharmaceutical Private Limitedthis company | ₹1.13 Cr (FY 2025) | ₹1.05 Lakh | 0.9% | -1.0% | Hyderabad, Telangana, India | |
| Sharma Agrotech Private Limited | ₹1.13 Cr (FY 2023) | 23016.0% | Indore, Madhya Pradesh, India | |||
| Hityshi Enterprises Private Limited | ₹1.13 Cr (FY 2024) | -22.0% | D B Nagr, West Bengal, India | |||
| Index Therapeutics Private Limited | ₹1.13 Cr (FY 2024) | 11.0% | Hyderabad, Telangana, India | |||
| AA Multi Trades Private Limited | ₹1.13 Cr (FY 2025) | -9.0% | Bhubaneswar, Odisha, India | |||
| Om Oil Company Private Limited | ₹1.13 Cr (FY 2016) | -3.0% | Jalgaon, Maharashtra, India |
To see the full peer comparison of Sylph Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sylph Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sylph Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sylph Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sylph Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Devi S L V K Lankalapalli was appointed as Director on 08 Sep 2020.
Frequently asked questions
Sylph Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 September 2020 (6+ years old) and is registered under CIN U24290TG2020PTC143646.
Sylph Pharmaceutical has 2 current directors:
- Nagarjuna Reddy Devireddy - Director
- Devi S L V K Lankalapalli - Director
The latest financial statements of Sylph Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sylph Pharmaceutical is U24290TG2020PTC143646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sylph Pharmaceutical was incorporated on 08 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sylph Pharmaceutical by revenue are Biospan Contamination Control Solutions Private Limited, Moovalley Agro Products Private Limited, Medicrux Healthcare Private Limited, Air Digilife Private Limited, Visamonk Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Devi S L V K Lankalapalli was appointed as Director on 08 Sep 2020. Nagarjuna Reddy Devireddy was appointed as Director on 08 Sep 2020.
The registered office of Sylph Pharmaceutical is at Plot No 44 Sy No 166, Sri Sai Nagar, Hyderabad, Telangana, India – 500072.
Sylph Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sylph Pharmaceutical is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.
Sylph Pharmaceutical can be reached at its registered office: Plot No 44 Sy No 166, Sri Sai Nagar, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
